Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_assertion type Assertion NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_head.
- NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_assertion description "[Left ventricular end systolic diameter increased and ejection fraction reduction was noted in the majority of R403W (MYH7) mutations in progression to hypertrophic cardiomyopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_provenance.
- NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_assertion evidence source_evidence_literature NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_provenance.
- NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_assertion SIO_000772 17612745 NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_provenance.
- NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_assertion wasDerivedFrom lhgdn-20090331 NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_provenance.
- NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_assertion wasGeneratedBy ECO_0000203 NP226906.RAb9HWXpto9haWBv4kfaA5I1mSXrOfwmAdxK9z-ns6CPA130_provenance.